How to Get the Best Deal on EpiPen and Alternatives | Consumer Reports

Despite a yearlong controversy over how EpiPen auto-injectors are priced, the lifesaving allergy medication is still far from cheap.

EpiPen was back in the news Thursday when drugmaker Mylan and the federal government finalized a $465 million settlement over allegations that Mylan overcharged Medicaid for the EpiPen as well as a generic version.

The settlement comes one year after Mylan suffered a firestorm of criticism from consumers and policymakers when it was revealed it had hiked—over the course of a decade—the price of a two-pack of EpiPen auto-injectors to more than $600.

Read complete article here:

How to Get the Best Deal on EpiPen and Alternatives – Consumer Reports.